RecruitingPhase 3NCT07011732
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Sponsor: Bristol-Myers Squibb
Salt Lake City, UT · +40 more sites
5 recruiting alzheimer's disease studies with a site in Salt Lake City, UT.
All trials in Salt Lake City, UT · All Alzheimer's Disease trials
Sponsor: Bristol-Myers Squibb
Salt Lake City, UT · +40 more sites
Sponsor: University of Michigan
Salt Lake City, UT · +6 more sites
Sponsor: University of Utah
Salt Lake City, UT
Sponsor: Eidos Therapeutics, a BridgeBio company
Salt Lake City, UT · +39 more sites
Sponsor: University of Utah
Salt Lake City, UT
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.